The first pass metabolism of nifedipine in man.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  1984-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1365-2125.1984.TB02569.XPMID 6529535PMCID PMC1463677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and metabolism of nifedipine.

  1983cited by this paper
• Determination of nifedipine in human plasma by capillary gas chromatography with nitrogen detection.

  1983cited by this paper
• Determination of nifedipine in serum or plasma by reversed-phase liquid chromatography.

  1983cited by this paper
• Nifedipine Kinetics and Bioavailability After Single Intravenous and Oral Doses in Normal Subjects

  1983cited by this paper
• Occurrence and measurement of nifedipine and its nitropyridine derivatives in human blood plasma.

  1982cited by this paper
• High-performance liquid chromatography of nifedipine, its metabolites and photochemical degradation products.

  1981cited by this paper
• [Clinical study on the pharmacokinetics of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].

  1972cited by this paper
• Clinical Investigations

  1952cited by this paper

• Therapeutic role of nifedipine in threatened preterm labor: Current evidence and future perspectives.

  2026cites this paper
• Use of Liquid Solid Technique for Development and Evaluation Study of Nifedipine Tablets to Enhance Dissolution Characteristics

  2025cites this paper
• Use of physiologically‐based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended‐release nifedipine

  2023cites this paper
• Nanomedicine for Maternal and Fetal Health.

  2023cites this paper
• LC-MS/MS Bioanalytical Method for the Quantitative Analysis of Nifedipine, Bisoprolol, and Captopril in Human Plasma: Application to Pharmacokinetic Studies.

  2023cites this paper
• Supercritical carbon dioxide solubility measurement and modelling for effective size reduction of nifedipine particles for transdermal application.

  2022cites this paper
• The Challenge and Importance of Integrating Drug–Nutrient–Genome Interactions in Personalized Cardiovascular Healthcare

  2022cites this paper
• Drug discovery with explainable artificial intelligence

  2020cites this paper
• In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization

  2020cites this paper
• Nifedipine degradation by an electro-oxidation process using titanium-based RuO2–IrO2–TiO2 mixed metal oxide electrode

  2020cites this paper
• Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis

  2020cites this paper
• Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women

  2017cites this paper
• Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.

  2016cites this paper
• Voltammetric Determination of Nifedipine at a Hanging Mercury Drop Electrode and a Mercury Meniscus Modified Silver Amalgam Electrode

  2015cites this paper
• Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Nifedipine.

  2015cites this paper
• Prediction of the extent and variation of grapefruit juice–drug interactions from the pharmacokinetic profile in the absence of grapefruit juice

  2014cites this paper
• Da‐Chaihu‐Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this

  2014cites this paper
• Utilizing in vitro and PBPK tools to link ADME characteristics to plasma profiles: case example nifedipine immediate release formulation.

  2013cites this paper
• INHIBITION OF CYP3A4-MEDIATED MIDAZOLAM METABOLISM BY REPEAT ORAL ADMINISTRATION OF ANCHUSAN IN HUMANS

  2013cites this paper
• Effects of Vernonia amygdalina Aqueous Leaf Extract on the Pharmacokinetics of Nifedipine in Rabbits

  2013cites this paper
• PREDICTION OF HUMAN SYSTEMIC, BIOLOGICALLY RELEVANTPHARMACOKINETIC PROPERTIES BASED ON PHYSICOCHEMICAL PROPERTIES OF CALCIUM CHANNEL BLOCKERS

  2012cites this paper
• Highly sensitive and rapid ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of nifedipine in human plasma and its application to a bioequivalence study.

  2012cites this paper
• Human cytosolic sulfotransferase 2B1b: Structure, function, and expression in human brain

  2011cites this paper
• Estimation of Isradipine in Human Plasma by LCMS/MS

  2011cites this paper
• Pharmacokinetic Interaction Between Atorvastatin and Nifedipine

  2010cites this paper
• Interactions between grapefruit juice and calcium channel antagonists.

  2009influential citation
• Effects of Turmeric Extract on the Pharmacokinetics of Nifedipine After a Single Oral Administration in Healthy Volunteers

  2008cites this paper
• Effects of Sairei‐to on the pharmacokinetics of nifedipine in rats

  2008cites this paper
• Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical herb-drug interaction study.

  2007cites this paper
• Genetic polymorphisms of the urea transporter gene are associated with antihypertensive response to nifedipine GITS.

  2007cites this paper
• Effect of a Single Glass of Grapefruit Juice on the Apparent Oral Bioavailability of the Dihydropyridine Calcium Channel Antagonist, Azelnidipine, in Healthy Japanese Volunteers

  2006cites this paper
• Improvement of Dispersion and Release Properties of Nifedipine in Suppositories by Complexation with 2-Hydroxypropyl-β-cyclodextrin

  2006cites this paper
• The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosin

  2004cites this paper
• Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma

  2004cites this paper
• Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects

  2004cites this paper
• Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure

  2004cites this paper
• CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers

  2004cites this paper
• Factors affecting the pharmacokinetics of nifedipine

  2004cites this paper
• Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats.

  2004cites this paper
• Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers.

  2004cites this paper
• Association between a G-protein β3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders

  2004cites this paper
• Pharmacokinetics of felodipine in patients with liver disease

  2004cites this paper
• Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms

  2004cites this paper
• Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats.

  2003cites this paper
• Determination of nifedipine in human plasma by solid-phase extraction and high-performance liquid chromatography: validation and application to pharmacokinetic studies.

  2003cites this paper
• Persistence of antihypertensive efficacy after missed doses: comparison of amlodipine and nifedipine gastrointestinal therapeutic system

  2002cites this paper
• First-derivative spectrophotometric and LC determination of nifedipine in Brij 96 based oil/water/oil multiple microemulsions on stability studies.

  2001cites this paper
• Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.

  2001cites this paper
• Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects

  2000cites this paper
• The effect of whole‐body sunbed ultraviolet A exposure on the pharmacokinetics of the photolabile drug nifedipine

  2000cites this paper
• Unterschiedliche Biotransformation von polycyclischen aromatischen Kohlenwasserstoffen bei Tier und Mensch als Basis für verschiedene biologische Wirksamkeit

  1999cites this paper
• Effects of grapefruit juice on the pharmacokinetics of the calcium channel blockers nifedipine and nisoldipine

  1998cites this paper
• The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard)

  1997cites this paper
• The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine.

  1997cites this paper
• Nifedipine/atenolol interactions in gastrointestinal absorption and biotransformation.

  1997cites this paper
• Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men

  1997cites this paper
• EXTRAHEPATIC FIRST‐PASS METABOLISM OF NIFEDIPINE IN THE RAT

  1997cites this paper
• Erythromycin‐felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice

  1996cites this paper
• Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine

  1996cites this paper
• Calcium channel blockers and vitamin E for tardive dyskinesia in adults with mental retardation

  1995cites this paper
• Factors affecting the absolute bioavailability of nifedipine.

  1995cites this paper
• Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.

  1995cites this paper
• Lack of presystemic metabolism of nifedipine in the rabbit

  1995cites this paper
• Impaired Mechanical Response to Calcium of Diabetic Rat Hearts: Reversal by Nifedipine Treatment

  1995cites this paper
• Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.

  1994cites this paper
• Pharmacokinetics of Oral Nifedipine in Different Populations

  1993cites this paper
• Long‐acting calcium antagonists: amlodipine versus nifedipine gastrointestinal therapeutic system (GITS)

  1993cites this paper
• The influences of dose and ethnic origins on the pharmacokinetics of nifedipine

  1993cites this paper
• Deuterated analogs of verapamil and nifedipine. Synthesis and biological activity

  1993cites this paper
• The Influence of Pretreatment Periods with Diltiazem on Nifedipine Kinetics

  1993cites this paper
• A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.

  1993cites this paper
• Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.

  1993cites this paper
• Human cytochrome P-450 enzymes.

  1992cites this paper
• The influence of posture on the pharmacokinetics of orally administered nifedipine.

  1992cites this paper
• Effect of an Acute Dose of Alcohol on the Pharmacokinetics of Oral Nifedipine in Humans

  1992cites this paper
• Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension.

  1992cites this paper
• Chronopharmacokinetics and cardiovascular effects of nifedipine.

  1991cites this paper
• Nonlinear first-pass metabolism of nifedipine in healthy subjects.

  1991cites this paper
• Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring.

  1991cites this paper
• Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

  1991cites this paper
• Myocardial metabolic and hemodynamic effects of a sustained intravenous infusion of nifedipine with and without metoprolol in patients with unstable angina.

  1991cites this paper
• OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist

  1991cites this paper
• Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.

  1991cites this paper
• Ethnic differences in the pharmacokinetics of oral nifedipine.

  1991cites this paper
• Sustained Release Nifedipine Formulations

  1991cites this paper
• Effects of nifedipine and propranolol on whole blood platelet aggregation.

  1991cites this paper
• Analysis of nifedipine and its pyridine metabolite dehydronifedipine in blood and plasma: review and improved high-performance liquid chromatographic methodology.

  1991cites this paper
• Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.

  1991cites this paper
• Chromatography of calcium channel blockers.

  1990cites this paper
• The combination of slow-release nifedipine and atenolol for stable angina

  1990cites this paper
• Serum concentrations and effects of (±)‐nicardipine compared with nifedipine in a population of healthy subjects

  1990cites this paper
• Effects of Diltiazem on the Pharmacokinetics of Nifedipin

  1990cites this paper
• Pharmacokinetics of Oral Nifedipine: Relevance of the Distribution Phase

  1989cites this paper
• Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules.

  1989cites this paper
• Comparison of intraluminally versus extraluminally administered nimodipine on serotonin-induced cerebral vascular responses in vitro and in situ.

  1989cites this paper
• Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.

  1989cites this paper
• Dose Dependent Effect of Diltiazem on the Pharmacokinetics of Nifedipine

  1989cites this paper
• Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure.

  1989cites this paper
• Serum binding of nifedipine and verapamil in patients with ischaemic heart disease on monotherapy.

  1989cites this paper
• The absolute oral bioavailability of selected drugs.

  1989cites this paper